Developer docs
API playgroundTry for free, no card

Search company profiles

ABEC

Full company profile

uuid0007xyz

Namestring
ABEC
Legal namestring
ABEC, Inc.
Websiteurl
abec.com
Company typeenum
Private
Founded yearint
1974
Descriptiontext

ABEC is a privately held bioprocess engineering solutions provider founded in 1974 and headquartered in Bethlehem, Pennsylvania. The company designs, manufactures, and services custom biopharmaceutical manufacturing systems—including CSR single-use bioreactors up to 6,000L, stainless-steel bioreactors and fermenters up to 30,000L+, and hybrid bioprocessing platforms—for biologic drug manufacturers, contract manufacturing organizations (CMOs), and cell and gene therapy developers. ABEC's technology stack includes the Advanced Therapy Bioreactor (ATB) for perfusion-driven cell therapy workflows, large-scale Tangential Flow Filtration (TFF) systems, the Synaptic HMI automation platform supporting Emerson DeltaV and Rockwell PlantPAx, and Process Sciences capabilities using CFD, FEA, and DoE for scale-up validation.

The company operates five manufacturing facilities totaling over 34,150 m² across the United States and Ireland, including three ISO-7 cleanrooms for single-use disposable container manufacturing, and maintains a global service network of 3,000 technicians supporting an installed base of 50,000+ bioprocess systems worldwide. ABEC monetizes through capital equipment sales for large-scale facility build-outs (e.g., WuXi Biologics Dundalk delivered in 26 months), recurring service contracts covering preventive maintenance, vessel services, modifications and retrofits, and OEM parts supply (20,000+ parts shipped 7 days a week). Go-to-market is direct enterprise sales to biopharma companies from conceptual design through validation and lifecycle support.

Customer concentration skews to large enterprise biopharma manufacturers, with named anchors including Eli Lilly, WuXi Biologics, Samsung Biologics, Fujifilm Diosynth Biotechnologies, and Thermo Fisher Scientific. A June 2025 announced acquisition by Magnesium Capital signals an ownership transition likely to accelerate growth investment. The company's differentiator is its claim to be the only global supplier offering fully customized single-use, stainless-steel, and hybrid bioprocess solutions—a custom-engineering model contrasting with competitors' standard catalog products.

Short descriptiontext

ABEC is a private bioprocess engineering company that designs, manufactures, and services custom single-use, stainless-steel, and hybrid bioreactor systems for biopharmaceutical manufacturers, CMOs, and cell/gene therapy developers across a global installed base of 50,000+ systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBethlehem, United States
HQ citystring
Bethlehem
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biopharmaceutical manufacturing, single-use bioreactors, stainless steel bioreactors, bioprocess engineering, fermentation equipment
Industry4 codes
PRIMARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAGAGAH
Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Other General Purpose Machinery Manufacturing3339
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • General Industrial Machinery & Equipment3560
  • Industrial Instruments For Measurement, Display, And Control3823
Product category
Bioprocess Manufacturing Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Biopharmaceutical Manufacturing Systems
TypeOne Time License
Description

ABEC designs, engineers, and manufactures custom bioprocess systems including single-use bioreactors, stainless-steel bioreactors, fermenters, and hybrid systems. Revenue is generated through capital equipment sales to biopharma manufacturers.

abec.com
2Service & Support
TypeProfessional Services
Description

Comprehensive lifecycle service including outsourced maintenance, vessel services, modifications and retrofits, part supply, automation support, engineering and consulting, and process science support. Services delivered globally through a network of 3,000 service technicians.

abec.com
3Parts Supply
TypeHardware Sales
Description

Supply of OEM and qualified replacement parts supporting routine maintenance, urgent repairs, and long-term lifecycle planning. Access to 20,000+ parts shipped 7 days a week.

abec.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Infrastructure, Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Custom enterprise solutions with pricing based on specifications
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed; custom quotes based on system specifications, capacity requirements, and configuration

abec.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Advanced Therapy Bioreactor (ATB™)
Description

Closed, automated single-use platform designed to support sensitive, perfusion-driven advanced therapy processes

abec.com
+2 more records
Core offering1 text field

ABEC designs, engineers, and manufactures custom bioprocess systems for the biopharmaceutical industry, including CSR single-use bioreactors up to 6,000L, stainless-steel bioreactors and fermenters from pilot scale to 30,000L+, and integrated hybrid single-use/stainless-steel platforms. The company also delivers comprehensive lifecycle services including outsourced maintenance, vessel services, modifications and retrofits, parts supply, automation support, engineering and consulting, and process science support through a global network of 3,000 service technicians.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 40-50% CAPEX reduction with single-use systems vs. stainless steel
+3 more records
Product overview1 text field

ABEC is a global provider of customized biopharmaceutical manufacturing solutions offering a comprehensive portfolio of products and services. The core offerings include CSR® Single-Use Systems (custom single-run bioreactors up to 6,000L), Stainless-Steel Systems (bioreactors and fermenters from pilot to 30,000L+), and Hybrid BioProcessing (integrated single-use and stainless-steel solutions). The Advanced Therapy Bioreactor (ATB™) supports cell and gene therapy workflows. Supporting services include Process Sciences (modeling, testing, validation), Automation (Synaptic™ HMI with platform support), and full lifecycle services including Outsourced Maintenance, Vessel Services, Modifications & Retrofits, Part Supply, Automation Support, and Engineering & Consulting. The Flexible Manufacturing Platform provides modular plant design combining all technologies.

Product and service13 records
1CSR® Single-Use Systems
CategorySingle-use bioprocess systems
Description

Custom Single Run (CSR) single-use bioreactors and fermenters engineered to deliver stainless-steel performance with single-use agility, supporting scalable multi-product operations with validated mixing, mass transfer, and predictable results. The product line spans up to 6,000L single-use systems enabling commercial-scale production. Targeted at biopharmaceutical manufacturers, CMOs, and advanced therapy developers.

2Stainless-Steel Systems
CategoryStainless-steel bioprocess systems
Description

Long-life engineered stainless-steel bioreactors and fermenters designed for reliability, reproducibility, and decades of continuous commercial-scale manufacturing. The product line spans pilot scale to 30,000L+ with patented fermenter design for large-scale cGMP processing. Targeted at biopharmaceutical manufacturers requiring durable, long-life production assets.

3Hybrid BioProcessing
CategoryHybrid bioprocess platforms
Description

Integrated hybrid solutions combining the flexibility of single-use with the durability of stainless steel, designed for evolving pipelines and multi-product facilities. Delivers adaptability without sacrificing performance. Targeted at biopharma manufacturers with multi-product facilities needing flexibility and durability.

4Advanced Therapy Bioreactor (ATB™)
CategoryCell and gene therapy bioprocess systems
Description

Closed, automated single-use bioreactor platform designed for sensitive, perfusion-driven advanced therapy workflows, providing controlled, reproducible performance for cell and gene therapy development and scale-out from 0.2L to 10L. Targeted at cell and gene therapy developers including CAR-T and other advanced therapy manufacturers.

5Automation (Synaptic™ HMI)
CategoryProcess automation systems
Description

Integrated automation systems with Synaptic HMI approach supporting Emerson DeltaV, Rockwell PlantPAx, and other supplier platforms, designed to deliver consistent control, reduce variability, and sustain performance across facilities. Targeted at biopharmaceutical manufacturers operating multi-platform automation environments.

6Outsourced Maintenance
CategoryLifecycle maintenance services
Description

Proactive maintenance programs across single-use, stainless-steel, and hybrid bioprocess systems to maximize uptime, extend asset life, and reduce unplanned work. Delivered globally through 3,000 service technicians performing 10,000+ preventative maintenance actions per year. Targeted at biopharmaceutical manufacturers operating ABEC and select third-party bioprocess equipment.

7Vessel Services
CategoryVessel lifecycle services
Description

Vessel inspection, restoration, and upgrade services including comprehensive inspection, surface remediation, electropolishing, and mechanical polishing to maintain vessel integrity across full lifecycle. Targeted at biopharmaceutical manufacturers needing vessel integrity assurance over decades of operation.

8Modifications & Retrofits
CategoryEngineering modification services
Description

Engineering-led modifications and retrofits for bioprocess platforms including process/mechanical modifications, agitation & mixing enhancements, thermal upgrades, automation & control updates, and CSR single-use hardware modifications. Targeted at existing biopharmaceutical manufacturers extending or modernizing installed ABEC systems.

9Part Supply
CategoryOEM parts supply
Description

OEM components and qualified replacement parts with traceability, supporting both ABEC-built equipment and select third-party systems, including critical spares programs and expedited fulfillment. Access to 20,000+ parts shipped 7 days a week. Targeted at biopharmaceutical manufacturers needing reliable spare parts supply.

10Automation Support
CategoryAutomation lifecycle services
Description

Lifecycle automation support including diagnostics, troubleshooting, platform updates & upgrades, legacy system modernization, recipe & control strategy updates, and configuration management. Targeted at biopharmaceutical manufacturers running ABEC automation platforms across multiple DCS environments.

11Engineering & Consulting
CategoryEngineering consulting services
Description

Manufacturing-first engineering consulting including process definition, system architecture & platform selection, facility planning, scale-up strategy, and technology evaluation. Targeted at biopharmaceutical manufacturers planning new facilities or major capacity expansions.

12Process Science Support
CategoryProcess science services
Description

Process characterization, performance validation, risk reduction & optimization services including mixing & mass transfer evaluation, scale-up analysis, process modeling, and comparability studies. Targeted at biopharmaceutical manufacturers requiring scale-up de-risking and process validation.

13Flexible Manufacturing Platform (FMP)
CategoryModular manufacturing facility design
Description

Hybrid, modular, integrated plant design combining single-use and stainless steel capabilities that can scale production capacity when market conditions are met, mitigating capacity investment risks. Targeted at biopharmaceutical manufacturers seeking flexible, modular facility capacity.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move14 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ABEC

Bioprocess Manufacturing Equipmentabec.com

ABEC is a private bioprocess engineering company that designs, manufactures, and services custom single-use, stainless-steel, and hybrid bioreactor systems for biopharmaceutical manufacturers, CMOs, and cell/gene therapy developers across a global installed base of 50,000+ systems.

What ABEC does

ABEC is a privately held bioprocess engineering solutions provider founded in 1974 and headquartered in Bethlehem, Pennsylvania. The company designs, manufactures, and services custom biopharmaceutical manufacturing systems—including CSR single-use bioreactors up to 6,000L, stainless-steel bioreactors and fermenters up to 30,000L+, and hybrid bioprocessing platforms—for biologic drug manufacturers, contract manufacturing organizations (CMOs), and cell and gene therapy developers. ABEC's technology stack includes the Advanced Therapy Bioreactor (ATB) for perfusion-driven cell therapy workflows, large-scale Tangential Flow Filtration (TFF) systems, the Synaptic HMI automation platform supporting Emerson DeltaV and Rockwell PlantPAx, and Process Sciences capabilities using CFD, FEA, and DoE for scale-up validation.

The company operates five manufacturing facilities totaling over 34,150 m² across the United States and Ireland, including three ISO-7 cleanrooms for single-use disposable container manufacturing, and maintains a global service network of 3,000 technicians supporting an installed base of 50,000+ bioprocess systems worldwide. ABEC monetizes through capital equipment sales for large-scale facility build-outs (e.g., WuXi Biologics Dundalk delivered in 26 months), recurring service contracts covering preventive maintenance, vessel services, modifications and retrofits, and OEM parts supply (20,000+ parts shipped 7 days a week). Go-to-market is direct enterprise sales to biopharma companies from conceptual design through validation and lifecycle support.

Customer concentration skews to large enterprise biopharma manufacturers, with named anchors including Eli Lilly, WuXi Biologics, Samsung Biologics, Fujifilm Diosynth Biotechnologies, and Thermo Fisher Scientific. A June 2025 announced acquisition by Magnesium Capital signals an ownership transition likely to accelerate growth investment. The company's differentiator is its claim to be the only global supplier offering fully customized single-use, stainless-steel, and hybrid bioprocess solutions—a custom-engineering model contrasting with competitors' standard catalog products.

ABEC firmographics

Firmographics
Name
ABEC
Legal name
ABEC, Inc.
Website
https://abec.com
Company type
Private
Founded year
1974
Operating status
Operating
Headcount range
501–1,000 employees
Short description
ABEC is a private bioprocess engineering company that designs, manufactures, and services custom single-use, stainless-steel, and hybrid bioreactor systems for biopharmaceutical manufacturers, CMOs, and cell/gene therapy developers across a global installed base of 50,000+ systems.
Ownership category
akta.pro rank

ABEC industry classification

Industry
Product category
Bioprocess Manufacturing Equipment
NAICS
Other General Purpose Machinery Manufacturing (3339), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
General Industrial Machinery & Equipment (3560), Industrial Instruments For Measurement, Display, And Control (3823)
akta.pro industry
PRIMARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAGAGAH
Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Biopharmaceutical manufacturing
  • Single-use bioreactors
  • Stainless steel bioreactors
  • Bioprocess engineering
  • Fermentation equipment

Where ABEC is headquartered

Location

Headquarters

HQ city
Bethlehem
HQ country
United States
HQ region
North America

Offices6 records

Markets served

ABEC business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Infrastructure, Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Biopharmaceutical Manufacturing Systems: ABEC designs, engineers, and manufactures custom bioprocess systems including single-use bioreactors, stainless-steel bioreactors, fermenters, and hybrid systems. Revenue is generated through capital equipment sales to biopharma manufacturers.
  2. Service & Support: Comprehensive lifecycle service including outsourced maintenance, vessel services, modifications and retrofits, part supply, automation support, engineering and consulting, and process science support. Services delivered globally through a network of 3,000 service technicians.
  3. Parts Supply: Supply of OEM and qualified replacement parts supporting routine maintenance, urgent repairs, and long-term lifecycle planning. Access to 20,000+ parts shipped 7 days a week.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise solutions with pricing based on specifications

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

ABEC product offering

Product offering

Core offering

ABEC designs, engineers, and manufactures custom bioprocess systems for the biopharmaceutical industry, including CSR single-use bioreactors up to 6,000L, stainless-steel bioreactors and fermenters from pilot scale to 30,000L+, and integrated hybrid single-use/stainless-steel platforms. The company also delivers comprehensive lifecycle services including outsourced maintenance, vessel services, modifications and retrofits, parts supply, automation support, engineering and consulting, and process science support through a global network of 3,000 service technicians.

Product overview

ABEC is a global provider of customized biopharmaceutical manufacturing solutions offering a comprehensive portfolio of products and services. The core offerings include CSR® Single-Use Systems (custom single-run bioreactors up to 6,000L), Stainless-Steel Systems (bioreactors and fermenters from pilot to 30,000L+), and Hybrid BioProcessing (integrated single-use and stainless-steel solutions). The Advanced Therapy Bioreactor (ATB™) supports cell and gene therapy workflows. Supporting services include Process Sciences (modeling, testing, validation), Automation (Synaptic™ HMI with platform support), and full lifecycle services including Outsourced Maintenance, Vessel Services, Modifications & Retrofits, Part Supply, Automation Support, and Engineering & Consulting. The Flexible Manufacturing Platform provides modular plant design combining all technologies.

Differentiator

Problem solved

Functional benefit

Brands

  • Advanced Therapy Bioreactor (ATB™): Closed, automated single-use platform designed to support sensitive, perfusion-driven advanced therapy processes
  • CSR® Custom Single Run
  • Flexible Manufacturing Platform (FMP)

Products and services

  • CSR® Single-Use Systems Custom Single Run (CSR) single-use bioreactors and fermenters engineered to deliver stainless-steel performance with single-use agility, supporting scalable multi-product operations with validated mixing, mass transfer, and predictable results. The product line spans up to 6,000L single-use systems enabling commercial-scale production. Targeted at biopharmaceutical manufacturers, CMOs, and advanced therapy developers.
  • Stainless-Steel Systems Long-life engineered stainless-steel bioreactors and fermenters designed for reliability, reproducibility, and decades of continuous commercial-scale manufacturing. The product line spans pilot scale to 30,000L+ with patented fermenter design for large-scale cGMP processing. Targeted at biopharmaceutical manufacturers requiring durable, long-life production assets.
  • Hybrid BioProcessing Integrated hybrid solutions combining the flexibility of single-use with the durability of stainless steel, designed for evolving pipelines and multi-product facilities. Delivers adaptability without sacrificing performance. Targeted at biopharma manufacturers with multi-product facilities needing flexibility and durability.
  • Advanced Therapy Bioreactor (ATB™) Closed, automated single-use bioreactor platform designed for sensitive, perfusion-driven advanced therapy workflows, providing controlled, reproducible performance for cell and gene therapy development and scale-out from 0.2L to 10L. Targeted at cell and gene therapy developers including CAR-T and other advanced therapy manufacturers.
  • Automation (Synaptic™ HMI) Integrated automation systems with Synaptic HMI approach supporting Emerson DeltaV, Rockwell PlantPAx, and other supplier platforms, designed to deliver consistent control, reduce variability, and sustain performance across facilities. Targeted at biopharmaceutical manufacturers operating multi-platform automation environments.
  • Outsourced Maintenance Proactive maintenance programs across single-use, stainless-steel, and hybrid bioprocess systems to maximize uptime, extend asset life, and reduce unplanned work. Delivered globally through 3,000 service technicians performing 10,000+ preventative maintenance actions per year. Targeted at biopharmaceutical manufacturers operating ABEC and select third-party bioprocess equipment.
  • Vessel Services Vessel inspection, restoration, and upgrade services including comprehensive inspection, surface remediation, electropolishing, and mechanical polishing to maintain vessel integrity across full lifecycle. Targeted at biopharmaceutical manufacturers needing vessel integrity assurance over decades of operation.
  • Modifications & Retrofits Engineering-led modifications and retrofits for bioprocess platforms including process/mechanical modifications, agitation & mixing enhancements, thermal upgrades, automation & control updates, and CSR single-use hardware modifications. Targeted at existing biopharmaceutical manufacturers extending or modernizing installed ABEC systems.
  • Part Supply OEM components and qualified replacement parts with traceability, supporting both ABEC-built equipment and select third-party systems, including critical spares programs and expedited fulfillment. Access to 20,000+ parts shipped 7 days a week. Targeted at biopharmaceutical manufacturers needing reliable spare parts supply.
  • Automation Support Lifecycle automation support including diagnostics, troubleshooting, platform updates & upgrades, legacy system modernization, recipe & control strategy updates, and configuration management. Targeted at biopharmaceutical manufacturers running ABEC automation platforms across multiple DCS environments.
  • Engineering & Consulting Manufacturing-first engineering consulting including process definition, system architecture & platform selection, facility planning, scale-up strategy, and technology evaluation. Targeted at biopharmaceutical manufacturers planning new facilities or major capacity expansions.
  • Process Science Support Process characterization, performance validation, risk reduction & optimization services including mixing & mass transfer evaluation, scale-up analysis, process modeling, and comparability studies. Targeted at biopharmaceutical manufacturers requiring scale-up de-risking and process validation.
  • Flexible Manufacturing Platform (FMP) Hybrid, modular, integrated plant design combining single-use and stainless steel capabilities that can scale production capacity when market conditions are met, mitigating capacity investment risks. Targeted at biopharmaceutical manufacturers seeking flexible, modular facility capacity.

Quantifiable outcome

  • 40-50% CAPEX reduction with single-use systems vs. stainless steel
  • +3 more outcomes

Companies that use ABEC

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

ABEC technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

ABEC partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves14 records

Expansion highlights5 records

ABEC competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

ABEC social profiles

Digital presence

ABEC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ABEC leadership team

Management profile

Number of profiles

Profiles2 records

ABEC funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ABEC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ABEC

What does ABEC do?

ABEC designs, engineers, and manufactures custom bioprocess systems for the biopharmaceutical industry, including CSR single-use bioreactors up to 6,000L, stainless-steel bioreactors and fermenters from pilot scale to 30,000L+, and integrated hybrid single-use/stainless-steel platforms. The company also delivers comprehensive lifecycle services including outsourced maintenance, vessel services, modifications and retrofits, parts supply, automation support, engineering and consulting, and process science support through a global network of 3,000 service technicians.

Is ABEC a public or private company?

ABEC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ABEC founded?

ABEC was founded in 1974. It employs 501 to 1,000 people.

Where is ABEC based?

ABEC is headquartered in Bethlehem, United States, in the North America region.

How does ABEC make money?

Three revenue lines are on record. Biopharmaceutical Manufacturing Systems are the primary driver. The others are service & Support and parts Supply.

Does ABEC have an API?

No public API is recorded for ABEC.

What industry is ABEC in?

ABEC's product category is Bioprocess Manufacturing Equipment. Its primary akta.pro industry code is HLAAAJAA, Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 3339 and its SIC code is 3560.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireABEC lance la plateforme ATB™-2100 pour transformer la fabrication des thérapies de pointeABEC launched the ATB-2100 cell expansion platform for advanced therapies, a closed, automated system for cell culture from preclinical to commercial scale. It supports T cells, iPSCs, and MSCs, maintaining constant surface-to-volume ratio from 200 mL to 10 L, enabling direct process transfer and reduced development time.PR NewswireABEC lance la plateforme ATB™-2100 pour transformer la fabrication des thérapies de pointeABEC launched the ATB-2100 cell expansion platform for advanced therapies, a closed, automated system supporting cell expansion from preclinical to commercial scale. It maintains a constant surface-to-volume ratio across 200 mL to 10 L volumes, enabling direct process transfer and reducing development time. The platform has demonstrated expansion of T cells, iPSCs, and MSCs.PR NewswireABEC bringt die ATB™-2100-Plattform auf den Markt, um die Herstellung fortschrittlicher Therapien zu revolutionierenABEC launched the ATB-2100 Advanced Therapy Bioreactor, a single-use cell culture platform for cell and gene therapy. The platform maintains a consistent membrane-to-volume ratio from 200 ml to 10 liters, enabling direct process transfer and reducing development time. It has demonstrated successful expansion of T cells, iPSCs, and MSCs.AktienABEC bringt die ATB-2100-Plattform auf den Markt, um die Herstellung fortschrittlicher Therapien zu revolutionierenABEC launched the ATB-2100 Advanced Therapy Bioreactor, a single-use platform for cell expansion in cell and gene therapy. The platform maintains a consistent membrane-to-volume ratio from 200 ml to 10 l, enabling direct scale-up and reducing development time. It has demonstrated successful expansion of T cells, iPSCs, and MSCs.PR NewswireABEC bringt die ATB™-2100-Plattform auf den Markt, um die Herstellung fortschrittlicher Therapien zu revolutionierenABEC launched the ATB-2100 Advanced Therapy Bioreactor, a single-use platform for cell expansion in cell and gene therapy. The platform maintains a consistent membrane-to-volume ratio from 200 ml to 10 l, enabling direct scale-up and reducing development time. It has demonstrated successful expansion of T cells, iPSCs, and MSCs.Third NewsABEC Unveils ATB™-2100: A Revolutionary Biopharmaceutical Manufacturing SolutionABEC launched the ATB-2100 bioreactor for advanced therapy manufacturing, featuring a closed, automated system with hollow fiber perfusion membranes. It scales from 200 ml to 10 liters while maintaining a consistent membrane-to-volume ratio, reducing development timelines and costs. The platform aims to streamline production from preclinical to commercial scale.PR NewswireABEC lanza la plataforma ATB™-2100 para transformar la fabricación de terapias avanzadasABEC launched the ATB-2100 bioreactor platform for advanced therapies, a single-use cell expansion system for cell and gene therapies. The platform scales from 200 ml to 10 liters, maintaining constant surface-area-to-volume ratio, and has demonstrated expansion of T cells, iPSCs, and MSCs.PR NewswireABEC lanza la plataforma ATB™-2100 para transformar la fabricación de terapias avanzadasABEC launched the ATB-2100 bioreactor platform for advanced therapies, a single-use cell expansion system for cell and gene therapies. The platform scales from 200 ml to 10 liters, maintaining constant surface-area-to-volume ratio, and has demonstrated expansion of T cells, iPSCs, and MSCs.PR NewswireABEC Launches ATB™-2100 Platform to Transform Advanced Therapy ManufacturingABEC launched the ATB-2100 Advanced Therapy Bioreactor, a single-use cell expansion platform for cell and gene therapies. It uses hollow-fiber perfusion membranes to maintain consistent surface-area-to-volume ratios from 200mL to 10L, enabling scalable manufacturing. The system has demonstrated expansion of T-cells, iPSCs, and MSCs.PR NewswireABEC Launches ATB™-2100 Platform to Transform Advanced Therapy ManufacturingABEC launched the ATB-2100 Advanced Therapy Bioreactor, a single-use cell expansion platform for cell and gene therapies. The system uses hollow-fiber perfusion membranes to maintain consistent surface-area-to-volume ratios from 200mL to 10L, enabling scalable manufacturing. It has demonstrated expansion of T-cells, iPSCs, and MSCs.